Hutchmed’s divestiture; Xgene reports Phase 2b win for non-opioid pain drug

Plus, news about Hookipa and Capricor Therapeutics: Hutchmed divests 45% stake in Chinese company: Hutchmed will get about $608 million in cash by divesting Shanghai Hutchison Pharmaceuticals Limited, which it described ...